RE:+5% ... reversing.....finally Still no word on what they will do with a year of cash. Since Tommyjones will not look at real facts in q1, they have exhausted their $21M in cash from Mar 31st and are already using the $17M they received for the plasma collection centres. That will last 2 months. They have $5M for plasma division and another approx $70M for voucher. But, they only have preclinical trials to work on listed in q1 presentation. That's about a year of cash with financing costs.
Why is management silent on any 4050 development? No mention of heart, liver or kidney at all in last year... wonder why? What happened to 4547? Just kinda disappeared, right? They have spent over $500M over past 4 years and sold Ryplazim as a result for a voucher. Great management!!!
tommyjones1 wrote:
Or sell and listen to stockbufoon ever changing stories.
News soon on those production jobs + voucher money (all in, about 100M$).
good luck.